Authors’ Reply to Braillon and Martin’s Comment on “Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)”

Priya Bahri (), Daniel R. Morales, Adrien Inoubli, Jean-Michel Dogné and Sabine M. J. M. Straus
Additional contact information
Priya Bahri: European Medicines Agency
Daniel R. Morales: University of Dundee
Adrien Inoubli: Agence Nationale de Sécurité du Médicament et des Produits de Santé
Jean-Michel Dogné: Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten-Agence Fédérale des Médicaments et des Produits de Santé
Sabine M. J. M. Straus: College ter Beoordeling van Geneesmiddelen

Drug Safety, 2021, vol. 44, issue 9, No 10, 1013 pages

Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-021-01096-6 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:44:y:2021:i:9:d:10.1007_s40264-021-01096-6

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-021-01096-6

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().